Has chemotherapy reached its limits in pediatric cancers? CommentaryVASSAL, Gilles; LOWIS, S; NEWELL, D. R et al.European journal of cancer (1990). 2005, Vol 41, Num 4, pp 564-577, issn 0959-8049, 14 p.Article

Busulfan, greffe de moelle et tumeurs cérébrales: Pharmacotoxicologie clinique et nouveaux modèles expérimentaux = Busulfan, bone marrow transplantation and brain tumors: Clinical pharmacotoxicology and new experimental modelsVassal, Gilles; Gouyette, A.1993, 187 p.Thesis

Liquid chromatography-tandem mass spectrometry assay of reduced and oxidized glutathione and main precursors in mice liverBOULIGAND, Jérome; DEROUSSENT, Alain; PACI, Angelo et al.Journal of chromatography. B. 2006, Vol 832, Num 1, pp 67-74, issn 1570-0232, 8 p.Article

High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical productsBOULIGAND, Jérome; PACI, Angelo; MERCIER, Lionel et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 3, pp 525-530, issn 0731-7085, 6 p.Article

Recherche précompétitive, une mise en synergie des ressources publiques et privées: pour quels objectifs, comment et dans quel cadre juridique ?VASSAL, Gilles; NEVES, Carole; ARNAUD, Olivier et al.Thérapie (Paris). 2011, Vol 66, Num 4, pp 301-307, issn 0040-5957, 7 p.Article

p53 pathway dysfunction in primary childhood ependymomasGASPAR, Nathalie; GRILL, Jacques; GEOERGER, Birgit et al.Pediatric blood & cancer. 2006, Vol 46, Num 5, pp 604-613, issn 1545-5009, 10 p.Article

High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adultsLE DELEY, Marie-Cécile; VASSAL, Gilles; TAÏBI, Ahmed et al.Pediatric blood & cancer. 2005, Vol 45, Num 1, pp 25-31, issn 1545-5009, 7 p.Article

High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastomaSARTELET, Hervé; OHTA, Shigeru; OLIGNY, Luc L et al.Histopathology. 2010, Vol 56, Num 5, pp 607-616, issn 0309-0167, 10 p.Article

MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene SignatureGASPAR, Nathalie; MARSHAL, Lynley; HARGRAVE, Darren et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 22, pp 9243-9252, issn 0008-5472, 10 p.Article

Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma : A joint study of the french society of pediatric oncology and the United Kingdom Children's cancer study groupVASSAL, Gilles; COUANET, Dominique; CISAR, Laura et al.Journal of clinical oncology. 2007, Vol 25, Num 4, pp 356-361, issn 0732-183X, 6 p.Article

Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIVLALANNE, Muriel; PACI, Angelo; ANDRIEUX, Karine et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 8, pp 2237-2240, issn 0960-894X, 4 p.Article

In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenograftsJOSEPH, Jean-Marc; GROSS, Nicole; LASSAU, Nathalie et al.International journal of cancer. 2005, Vol 113, Num 6, pp 881-890, issn 0020-7136, 10 p.Article

In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterationsSANTOS, Alexandre; CALVET, Loreley; TERRIER-LACOMBE, Marie-Josee et al.Cancer research (Baltimore). 2004, Vol 64, Num 9, pp 3223-3229, issn 0008-5472, 7 p.Article

Les adénovirus réplicatifs conditionnels : un second souffle pour la thérapie génique du cancer = Conditionally replicative adenoviruses: a second wind for cancer gene therapyGRILL, Jacques; GEOERGER, Birgit; LAMFERS, Martine et al.Bulletin du cancer. 2003, Vol 90, Num 12, pp 1039-1048, issn 0007-4551, 10 p.Article

A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration StudyPAPPO, Alberto S; VASSAL, Gilles; CHAWLA, Sant P et al.Cancer. 2014, Vol 120, Num 16, pp 2448-2456, issn 0008-543X, 9 p.Article

Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyGEOERGER, Birgit; CHISHOLM, Julia; DEVOS, Annick et al.European journal of cancer (1990). 2011, Vol 47, Num 2, pp 230-238, issn 0959-8049, 9 p.Article

Quantification of dimethyl-ifosfamide and its N-deschloropropylated metabolites in mouse plasma by liquid chromatography-tandem mass spectrometryDEROUSSENT, Alain; RODRIGUEZ, Stephanie; MARTELLI, Sonia et al.Journal of chromatography. B. 2011, Vol 879, Num 11-12, pp 743-750, issn 1570-0232, 8 p.Article

Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastomaGEOERGER, Birgit; BRASME, Jean-François; DAUDIGEOS-DUBUS, Estelle et al.European journal of cancer (1990). 2010, Vol 46, Num 18, pp 3251-3262, issn 0959-8049, 12 p.Article

EGFR Inhibition Using Gefitinib Is Not Active in Neuroblastoma Cell LinesRÖSSLER, Jochen; ODENTHAL, Eva; GEOERGER, Birgit et al.Anticancer research. 2009, Vol 29, Num 4, pp 1327-1333, issn 0250-7005, 7 p.Article

Metabolism evaluation of biomimetic prodrugs by in vitro models and mass spectrometryLALANNE, Muriel; KHOURY, Hania; DEROUSSENT, Alain et al.International journal of pharmaceutics (Print). 2009, Vol 379, Num 2, pp 235-243, issn 0378-5173, 9 p.Article

A phase II study of irinotecan in children with relapsed or refractory neuroblastoma : A European cooperation of the Société Francaise d'Oncologie Pediatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)VASSAL, Gilles; GIAMMARILE, Francesco; PICHON, Fabienne et al.European journal of cancer (1990). 2008, Vol 44, Num 16, pp 2453-2460, issn 0959-8049, 8 p.Article

Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and AdultsRETAIN, Aurélie; KATTYGNARATH, Darouna; AZARD, Julie et al.Clinical cancer research (Print). 2008, Vol 14, Num 21, pp 7102-7109, issn 1078-0432, 8 p.Article

In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenograftsVASSAL, Gilles; MERLIN, Jean-Louis; LUCAS, Catherine et al.Cancer chemotherapy and pharmacology. 2003, Vol 51, Num 5, pp 385-394, issn 0344-5704, 10 p.Article

Potential of the conditionally replicative adenovirus Ad5-Δ24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapyLAMFERS, Martine L. M; GRILL, Jacques; PINEDO, Herbert M et al.Cancer research (Baltimore). 2002, Vol 62, Num 20, pp 5736-5742, issn 0008-5472, 7 p.Article

Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effectURIEN, Saik; DOZ, François; RUBIE, Hervé et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 3, pp 597-603, issn 0344-5704, 7 p.Article